title: [Useful tools for documenting urticaria].
abstract: Urticaria is one of the most common inflammatory skin diseases. Many patients suffer for many years of the subtypes of urticaria. Because of their symptoms, urticaria patients have a very low quality of life and are subject to comorbidities. A structured approach with validated evaluation tools helps (1) to diagnose the respective subtype of the disease, (2) to define the disease activity and (3) to analyze the impact on quality of life. By virtue of this, it is possible to adequately diagnose and manage urticaria patients without major investment of time or manpower. Tools to measure disease intensity (urticaria activity score, angioedema activity score) and questionnaires for quality of life in the cases of chronic urticaria and angioedema have been developed. Suspected diagnoses of comorbidity such as depression or anxiety can be confirmed by the appropriate questionnaire (Hamilton Anxiety Depression Scale [HADS]). In addition diagnostic instruments are helpful to define the intensity of the disease, especially in cases of inducible urticaria. All these forms, scores and questionnaires are easy to learn and employ in daily practice.
authors.affiliation: Hautklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland, petra.staubach@unimedizin-mainz.de.
authors.forename: P
authors.initials: P
authors.lastname: Staubach
authors.forename: A
authors.initials: A
authors.lastname: Groffik
mesh_terms: D000203:Activities of Daily Living; D004282:Documentation / Q000379:methods*; D006801:Humans; D010808:Physical Examination / Q000379:methods; D011594:Psychometrics / Q000379:methods*; D011788:Quality of Life; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D014581:Urticaria / Q000145:classification / Q000175:diagnosis* / Q000523:psychology*
references.citation: Br J Dermatol. 2006 Feb;154(2):294-8
references.pmid: 16433799
references.citation: Clin Exp Dermatol. 1994 May;19(3):210-6
references.pmid: 8033378
references.citation: Arch Dermatol. 2011 Oct;147(10):1221-3
references.pmid: 22006145
references.citation: J Allergy Clin Immunol. 2004 Nov;114(5):1224-5
references.pmid: 15536435
references.citation: Allergy. 2009 Oct;64(10):1427-43
references.pmid: 19772513
references.citation: Allergy. 2009 Jun;64(6):927-36
references.pmid: 19453340
references.citation: Allergy. 2008 Jun;63(6):777-80
references.pmid: 18445192
references.citation: Allergy. 2013 Sep;68(9):1185-92
references.pmid: 23919330
references.citation: Allergy. 2009 Oct;64(10):1417-26
references.pmid: 19772512
references.citation: Hautarzt. 2010 Sep;61(9):750-7
references.pmid: 20694454
references.citation: Acta Derm Venereol. 2011 Sep;91(5):557-61
references.pmid: 21597672
references.citation: J Psychosom Res. 1997 Jan;42(1):17-41
references.pmid: 9055211
references.citation: Psychother Psychosom Med Psychol. 1999 Feb;49(2):48-54
references.pmid: 10098392
references.citation: Br J Dermatol. 2010 Jan;162(1):198-200
references.pmid: 19785601